JnJ keeps vaccine sales outlook unchanged after Q3 miss Ruchika Sharma20 Oct 2021 7:24 AM GMTNew Delhi: Johnson & Johnson on Tuesday reported lower-than- expected quarterly revenue after sales of its COVID-19 vaccine missed Wall...
Analysis of JnJ COVID booster data by USFDA scientists raises red flags Ruchika Sharma14 Oct 2021 7:00 AM GMTUS: U.S. Food and Drug Administration scientists said on Wednesday they did not receive enough data in time to do their own analysis of Johnson &...
JnJ, Moderna COVID vaccine third dose efficacy to be evaluated by USFDA this week MD Bureau13 Oct 2021 8:30 AM GMTWashington: The US Food and Drug Administration is expected to evaluate the efficacy of Moderna and Johnson & Johnson's third dose of Covid...
Use only ICMR approved kits for rapid serological test: CDSCO panel tells JnJ on Ad26.COV2.S study Medical Dialogues Team10 Oct 2021 6:00 AM GMTNew Delhi: Reiterating the prior suggestion, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has opined...
JnJ plans to seek USFDA authorization for booster shot of Covid-19 vaccine Ruchika Sharma5 Oct 2021 9:00 AM GMTNew Delhi: Johnson & Johnson is planning to ask U.S. federal regulators this week to authorize a booster shot of its COVID-19 vaccine, the...
India set to get first JnJ COVID vaccine doses in October: Report Ruchika Sharma22 Sep 2021 6:30 AM GMTNew Delhi: India expects to get its first Johnson & Johnson COVID-19 vaccine doses from next month, filled and finished in India by a partner...
Second shot boosts protection for moderate-severe Covid-19 to 94 percent: JnJ Ruchika Sharma22 Sep 2021 4:30 AM GMTNew Delhi: Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness...
Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sep 2021 5:00 AM GMTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sep 2021 4:00 AM GMTNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson &...
Covid-19: Aspen Pharmacare eyes Serum Institute model as it seeks licence to make JnJ vaccine Ruchika Sharma4 Sep 2021 3:30 AM GMTJohannesburg: South Africa's Aspen Pharmacare wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson &...
JnJ HIV vaccine fails Imbokodo trial Ruchika Sharma1 Sep 2021 11:24 AM GMTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 3:30 AM GMTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people...
